Our fourth quarter and full year 2025 results were released this afternoon and are available on the SEC’s EDGAR system and on our website, Joining me on today’s call is Mihael H. Polymeropoulos, our ...

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript February 11, 2026 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-2.39 EPS, expectations were ...

Vanda Pharmaceuticals had 9% revenue growth and heavy losses with a 1.4x sales valuation and a PDUFA date. Check out why VNDA stock is downgraded to hold.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter ...

Despite a 9% revenue increase, Vanda Pharmaceuticals Inc (VNDA) faces significant net losses and rising operating expenses.

The FDA has set a Feb. 21 target decision on the Bysanti NDA. ・Vanda submitted the NDA in March 2025 for Bysanti to treat acute bipolar I disorder and schizophrenia. ・In May, the FDA said the ...

Full year 2025 Fanapt® net product sales increased by 24% to $117.3 million compared to full year 2024 Full year 2025 total revenues increased by 9% to $216.1 million ...

Add Yahoo as a preferred source to see more of our stories on Google. Ruel is the winner of the 2025 Vanda & Young Global Songwriting Competition, snagging the lucrative contest for his release “The ...

WASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2025 on Wednesday, February 11, ...

The D.C. biotech also filed a shelf registration statement for $200 million, opening the door for it to raise that money over ...

Individual investors on Monday sent about $171 million on net into the iShares Silver Trust (SLV), a popular exchange-traded ...

In the lead-up to the inaugural sailing of Disney Adventure from Singapore on 10 March, Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line ...